Nanorobots that Swim Through Blood to Deliver Drugs

Estimated reading time: 1 minute

Someday, treating patients with nanorobots could become standard practice to deliver medicine specifically to parts of the body affected by disease. But merely injecting drug-loaded nanoparticles might not always be enough to get them where they need to go. Now scientists are reporting in the ACS journal Nano Letters the development of new nanoswimmers that can move easily through body fluids to their targets.

Tiny robots could have many benefits for patients. For example, they could be programmed to specifically wipe out cancer cells, which would lower the risk of complications, reduce the need for invasive surgery and lead to faster recoveries. It's a burgeoning field of study with early-stage models currently in development in laboratories. But one of the challenges to making these robots work well is getting them to move through body fluids, which are like molasses to something as small as a nanorobot. Bradley J. Nelson, Salvador Pané, Yizhar Or and colleagues wanted to address this problem.

The researchers strung together three links in a chain about as long as a silk fiber is wide. One segment was a polymer, and two were magnetic, metallic nanowires. They put the tiny devices in a fluid even thicker than blood. And when they applied an oscillating magnetic field, the nanoswimmer moved in an S-like, undulatory motion at the speed of nearly one body length per second. The magnetic field also can direct the swimmers to reach targets.

The authors acknowledge funding from the European Community's Seventh Framework Programme, the European Research Council, the Israel Science Foundation.

About American Chemical Society

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

For more information, please click here.